21 CFR Part 11 | Electronic Records & Electronic Signatures | GxP Computer System requirements
The presentation discusses details of 21 CFR Part 11 requirements and guidance for industry for the same. Details of Part 11 requirements for Electronic Records, Electronic Signatures, Validation of Computerized System, Audit trail, Handwritten signatures has been explained. Discretion of legacy system along with requirements for validation, retention has been defined. About the channel: The channel has been developed with view of sharing information on Pharmaceutical Guidelines & Guidance. Kindly subscribe to channel at: / @proftalks1680
▶︎
Quality Metrics Data Submission USFDA Guidance| USFDA Guidelines |
▶︎
21 CFR, Parts 210 and 211
▶︎
EU GMP Annex 11 - Expectations & Evaluation
▶︎
Electronic records and electronic signatures according to 21 CFR Part 11
▶︎
Computer System Validation (CSV) Testing Explained | GAMP 5 (2nd Ed), FDA CSA & EU Annex 11
▶︎
Revised ICH Q9 (R1) Quality Risk Management Guideline | Jan 2023
▶︎
The Importance of Computer System Validation for Regulated Systems
▶︎
BREAKING: Trump’s Epstein problem returns with blockbuster testimony
▶︎
Something is jamming GPS over Europe. Here's what we found
▶︎
The FDA Drug Development Process: GLP, GMP and GCP Regulations
▶︎
Brief on Computerized System Validation
▶︎
USFDA Guidance for Data Integrity | USFDA Guidelines for Pharmaceutical | Easy Explanation
▶︎
USFDA Inspections: Overview | Difference between USFDA Inspection & Other Authority Inspections
▶︎
ICH Q9 Guidance for Quality Risk Management | With simplified example
▶︎
Computer Systems Validation and Part 11.
▶︎
Trump Attends NBA Finals, Cries Election Fraud in California & Storms Out of Interview
▶︎
System Design Course – APIs, Databases, Caching, CDNs, Load Balancing & Production Infra
▶︎
EudraLex Volume 4, Annex 1 - How Will It Affect You?
▶︎
Nitrosamine Impurities-Aug 2023 NDSRIs Limit USFDA Guidance | Control of Nitrosamine Guidance Feb-21
▶︎